Literature DB >> 31375813

Massively parallel single-cell chromatin landscapes of human immune cell development and intratumoral T cell exhaustion.

Ansuman T Satpathy1,2, Jeffrey M Granja1,3,4, Kathryn E Yost1,5,6, Yanyan Qi1,6, Francesca Meschi7, Geoffrey P McDermott7, Brett N Olsen7, Maxwell R Mumbach1,3, Sarah E Pierce3,5, M Ryan Corces1,6, Preyas Shah7, Jason C Bell7, Darisha Jhutty7, Corey M Nemec7, Jean Wang7, Li Wang7, Yifeng Yin7, Paul G Giresi7, Anne Lynn S Chang6, Grace X Y Zheng8, William J Greenleaf9,10,11,12, Howard Y Chang13,14,15,16.   

Abstract

Understanding complex tissues requires single-cell deconstruction of gene regulation with precision and scale. Here, we assess the performance of a massively parallel droplet-based method for mapping transposase-accessible chromatin in single cells using sequencing (scATAC-seq). We apply scATAC-seq to obtain chromatin profiles of more than 200,000 single cells in human blood and basal cell carcinoma. In blood, application of scATAC-seq enables marker-free identification of cell type-specific cis- and trans-regulatory elements, mapping of disease-associated enhancer activity and reconstruction of trajectories of cellular differentiation. In basal cell carcinoma, application of scATAC-seq reveals regulatory networks in malignant, stromal and immune cells in the tumor microenvironment. Analysis of scATAC-seq profiles from serial tumor biopsies before and after programmed cell death protein 1 blockade identifies chromatin regulators of therapy-responsive T cell subsets and reveals a shared regulatory program that governs intratumoral CD8+ T cell exhaustion and CD4+ T follicular helper cell development. We anticipate that scATAC-seq will enable the unbiased discovery of gene regulatory factors across diverse biological systems.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31375813      PMCID: PMC7299161          DOI: 10.1038/s41587-019-0206-z

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  81 in total

1.  NR4A transcription factors limit CAR T cell function in solid tumours.

Authors:  Joyce Chen; Isaac F López-Moyado; Hyungseok Seo; Chan-Wang J Lio; Laura J Hempleman; Takashi Sekiya; Akihiko Yoshimura; James P Scott-Browne; Anjana Rao
Journal:  Nature       Date:  2019-02-27       Impact factor: 49.962

2.  Constitutive Glycolytic Metabolism Supports CD8+ T Cell Effector Memory Differentiation during Viral Infection.

Authors:  Anthony T Phan; Andrew L Doedens; Asis Palazon; Petros A Tyrakis; Kitty P Cheung; Randall S Johnson; Ananda W Goldrath
Journal:  Immunity       Date:  2016-11-08       Impact factor: 31.745

3.  Cicero Predicts cis-Regulatory DNA Interactions from Single-Cell Chromatin Accessibility Data.

Authors:  Hannah A Pliner; Jonathan S Packer; José L McFaline-Figueroa; Darren A Cusanovich; Riza M Daza; Delasa Aghamirzaie; Sanjay Srivatsan; Xiaojie Qiu; Dana Jackson; Anna Minkina; Andrew C Adey; Frank J Steemers; Jay Shendure; Cole Trapnell
Journal:  Mol Cell       Date:  2018-08-02       Impact factor: 17.970

4.  A vital role for interleukin-21 in the control of a chronic viral infection.

Authors:  John S Yi; Ming Du; Allan J Zajac
Journal:  Science       Date:  2009-05-14       Impact factor: 47.728

Review 5.  Networking erythropoiesis.

Authors:  Marc A Kerenyi; Stuart H Orkin
Journal:  J Exp Med       Date:  2010-11-22       Impact factor: 14.307

6.  Control of effector CD8+ T cell function by the transcription factor Eomesodermin.

Authors:  Erika L Pearce; Alan C Mullen; Gislâine A Martins; Connie M Krawczyk; Anne S Hutchins; Valerie P Zediak; Monica Banica; Catherine B DiCioccio; Darrick A Gross; Chai-An Mao; Hao Shen; Nezih Cereb; Soo Y Yang; Tullia Lindsten; Janet Rossant; Christopher A Hunter; Steven L Reiner
Journal:  Science       Date:  2003-11-07       Impact factor: 47.728

7.  Non-conventional Inhibitory CD4+Foxp3-PD-1hi T Cells as a Biomarker of Immune Checkpoint Blockade Activity.

Authors:  Roberta Zappasodi; Sadna Budhu; Matthew D Hellmann; Michael A Postow; Yasin Senbabaoglu; Sasikanth Manne; Billel Gasmi; Cailian Liu; Hong Zhong; Yanyun Li; Alexander C Huang; Daniel Hirschhorn-Cymerman; Katherine S Panageas; E John Wherry; Taha Merghoub; Jedd D Wolchok
Journal:  Cancer Cell       Date:  2018-06-11       Impact factor: 31.743

8.  TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.

Authors:  Sanjeev Mariathasan; Shannon J Turley; Dorothee Nickles; Alessandra Castiglioni; Kobe Yuen; Yulei Wang; Edward E Kadel; Hartmut Koeppen; Jillian L Astarita; Rafael Cubas; Suchit Jhunjhunwala; Romain Banchereau; Yagai Yang; Yinghui Guan; Cecile Chalouni; James Ziai; Yasin Şenbabaoğlu; Stephen Santoro; Daniel Sheinson; Jeffrey Hung; Jennifer M Giltnane; Andrew A Pierce; Kathryn Mesh; Steve Lianoglou; Johannes Riegler; Richard A D Carano; Pontus Eriksson; Mattias Höglund; Loan Somarriba; Daniel L Halligan; Michiel S van der Heijden; Yohann Loriot; Jonathan E Rosenberg; Lawrence Fong; Ira Mellman; Daniel S Chen; Marjorie Green; Christina Derleth; Gregg D Fine; Priti S Hegde; Richard Bourgon; Thomas Powles
Journal:  Nature       Date:  2018-02-14       Impact factor: 49.962

9.  TOX is a critical regulator of tumour-specific T cell differentiation.

Authors:  Andrew C Scott; Friederike Dündar; Paul Zumbo; Smita S Chandran; Christopher A Klebanoff; Mojdeh Shakiba; Prerak Trivedi; Laura Menocal; Heather Appleby; Steven Camara; Dmitriy Zamarin; Tyler Walther; Alexandra Snyder; Matthew R Femia; Elizabeth A Comen; Hannah Y Wen; Matthew D Hellmann; Niroshana Anandasabapathy; Yong Liu; Nasser K Altorki; Peter Lauer; Olivier Levy; Michael S Glickman; Jonathan Kaye; Doron Betel; Mary Philip; Andrea Schietinger
Journal:  Nature       Date:  2019-06-17       Impact factor: 49.962

10.  GLI activation by atypical protein kinase C ι/λ regulates the growth of basal cell carcinomas.

Authors:  Scott X Atwood; Mischa Li; Alex Lee; Jean Y Tang; Anthony E Oro
Journal:  Nature       Date:  2013-02-28       Impact factor: 49.962

View more
  189 in total

1.  SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery.

Authors:  Siwen Hu-Lieskovan; Srabani Bhaumik; Kavita Dhodapkar; Jean-Charles J B Grivel; Sumati Gupta; Brent A Hanks; Sylvia Janetzki; Thomas O Kleen; Yoshinobu Koguchi; Amanda W Lund; Cristina Maccalli; Yolanda D Mahnke; Ruslan D Novosiadly; Senthamil R Selvan; Tasha Sims; Yingdong Zhao; Holden T Maecker
Journal:  J Immunother Cancer       Date:  2020-12       Impact factor: 13.751

2.  Single-cell chromatin accessibility landscape identifies tissue repair program in human regulatory T cells.

Authors:  Michael Delacher; Malte Simon; Lieke Sanderink; Agnes Hotz-Wagenblatt; Marina Wuttke; Kathrin Schambeck; Lisa Schmidleithner; Sebastian Bittner; Asmita Pant; Uwe Ritter; Thomas Hehlgans; Dania Riegel; Verena Schneider; Florian Kai Groeber-Becker; Andreas Eigenberger; Claudia Gebhard; Nicholas Strieder; Alexander Fischer; Michael Rehli; Petra Hoffmann; Matthias Edinger; Till Strowig; Jochen Huehn; Christian Schmidl; Jens M Werner; Lukas Prantl; Benedikt Brors; Charles D Imbusch; Markus Feuerer
Journal:  Immunity       Date:  2021-03-30       Impact factor: 31.745

Review 3.  Navigating CAR-T cells through the solid-tumour microenvironment.

Authors:  Andrew J Hou; Laurence C Chen; Yvonne Y Chen
Journal:  Nat Rev Drug Discov       Date:  2021-05-10       Impact factor: 84.694

Review 4.  A plate-based single-cell ATAC-seq workflow for fast and robust profiling of chromatin accessibility.

Authors:  Wei Xu; Yi Wen; Yingying Liang; Qiushi Xu; Xuefei Wang; Wenfei Jin; Xi Chen
Journal:  Nat Protoc       Date:  2021-07-19       Impact factor: 13.491

Review 5.  Genome editing to define the function of risk loci and variants in rheumatic disease.

Authors:  Yuriy Baglaenko; Dana Macfarlane; Alexander Marson; Peter A Nigrovic; Soumya Raychaudhuri
Journal:  Nat Rev Rheumatol       Date:  2021-06-29       Impact factor: 20.543

Review 6.  Emerging technologies for systems vaccinology - multi-omics integration and single-cell (epi)genomic profiling.

Authors:  Florian Wimmers; Bali Pulendran
Journal:  Curr Opin Immunol       Date:  2020-06-03       Impact factor: 7.486

7.  Stereo3D: using stereo images to enrich 3D visualization.

Authors:  Yang Liu; Vinod Kumar Singh; Deyou Zheng
Journal:  Bioinformatics       Date:  2020-08-15       Impact factor: 6.937

8.  A human cell atlas of fetal chromatin accessibility.

Authors:  Silvia Domcke; Andrew J Hill; Riza M Daza; Junyue Cao; Diana R O'Day; Hannah A Pliner; Kimberly A Aldinger; Dmitry Pokholok; Fan Zhang; Jennifer H Milbank; Michael A Zager; Ian A Glass; Frank J Steemers; Dan Doherty; Cole Trapnell; Darren A Cusanovich; Jay Shendure
Journal:  Science       Date:  2020-11-13       Impact factor: 47.728

9.  Epigenomic State Transitions Characterize Tumor Progression in Mouse Lung Adenocarcinoma.

Authors:  Lindsay M LaFave; Vinay K Kartha; Sai Ma; Kevin Meli; Isabella Del Priore; Caleb Lareau; Santiago Naranjo; Peter M K Westcott; Fabiana M Duarte; Venkat Sankar; Zachary Chiang; Alison Brack; Travis Law; Haley Hauck; Annalisa Okimoto; Aviv Regev; Jason D Buenrostro; Tyler Jacks
Journal:  Cancer Cell       Date:  2020-07-23       Impact factor: 31.743

Review 10.  Advancing Cancer Research and Medicine with Single-Cell Genomics.

Authors:  Bora Lim; Yiyun Lin; Nicholas Navin
Journal:  Cancer Cell       Date:  2020-04-13       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.